Society ❯ Ethics

Reproductive Rights

Abortion Women's Rights Abortion Debate Abortion Access Abortion Rights Pro-Life Movement Women's Health Access to Healthcare Public Opinion Surrogacy Parental Consent Anti-Abortion Movement Women’s Rights Pro-Life vs Pro-Choice Fertility Tourism Embryo Rights Genetic Identity Pro-Choice Movement Fertility Treatments Frozen Embryos In-Vitro Fertilization (IVF) Anti-Abortion Groups Church and State Political Controversies Political Actions Medical Ethics Abortion Controversy Personhood Movement Abortion Exceptions Minor Rights State Legislation Coercion in Healthcare Pro-life Movement Personhood of Embryos Sperm Donation Regulations Legal Challenges Unregulated Practices Donor Anonymity Surrogacy Debate Personhood Laws Women’s Health Healthcare Access Human Rights Public Health Personhood Family Dynamics Legal Protections Embryo Storage

Judge Pauses Louisiana Challenge, Leaves Mail-Order Abortion Pill Policy Intact

The court stay gives the FDA time to finish a promised safety review of mifepristone.

Montgomery County Man Charged After Alleged Covert Abortion Drug Leads to Stillbirth

Live Action Urges HHS and FDA to Suspend Mifepristone After Undercover Planned Parenthood Calls

Republicans Push to Restore In‑Person Rules for Abortion Pill at Fiery Senate Hearing

Kentucky Prosecutor Drops Fetal Homicide Charge in Self-Managed Abortion Case

Louisiana Joins Texas, Florida in New Court Moves Targeting FDA Abortion Pill Rules

Hawley Pressures FDA Chief as Anti‑Abortion Groups Demand Firing Over Reported Mifepristone Review Delay

Missouri, Kansas and Idaho Sue to Block FDA’s New Generic Mifepristone Approval, Curb Mail-Order Access

Florida Sues Planned Parenthood Over ‘Safer Than Tylenol’ Abortion Pill Claim, Seeks $350 Million

Senate Democrats Press FDA on Mifepristone Review After Court Strikes Down Restrictions

17 GOP Senators Press FDA Over Generic Mifepristone Approval

GOP Senators Move to Curb Mifepristone After FDA Clears Second Generic

FDA Confirms Safety Review of Mifepristone With No Regulatory Changes Yet

FDA Approves Second Generic Mifepristone as White House Cites Legal Obligation

Andy Cohen Rebukes Navratilova’s ‘Ill-Informed and Dumb’ Surrogacy Stance

GOP Attorneys General Urge Ban on State Abortion Shield Laws

Medina Ruling and Budget Bill Threaten Planned Parenthood’s Medicaid Funding

Texas House Advances Bipartisan Bill Clarifying Abortion Ban Exceptions

Georgia Family Challenges Life Support for Brain-Dead Pregnant Woman Under State Law